ConductScience.org, home

Paper19038618

Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.

Toris CB and 2 others. Surv Ophthalmol, 2008. Cited by 236 papers, by iCite.

Cite this record

ConductScience Library. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Papers, record 19038618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19038618

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.
PubMed
Journal
Surv Ophthalmol
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
236
iCite
Relative citation ratio, by iCite
8.97
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Toris CBCarol B
2Gabelt BTB'Ann T
3Kaufman PLPaul L

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
Glaucoma, Open-AngleMajor topic
Intraocular PressureMajor topic
Prostaglandins F, SyntheticMajor topic
Administration, Topical
Animals
Aqueous Humor
Humans
Ocular Hypertension

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 EY016665NEI NIH HHSUnited StatesP30EY016665PubMed and NIHNIH RePORTER
R01 EY002698NEI NIH HHSUnited StatesR01EY002698PubMed and NIHNIH RePORTER
EY002698NEI NIH HHSUnited StatesR01EY002698PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07074782Retinal Ganglion Cell Neuroprotection Under Prostaglandin AnaloguesBackground

Source ClinicalTrials.gov

Download CSV of trials

References89

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116109646Prostaglandins E1 and E2, but not F2alpha or latanoprost, inhibit monkey ciliary muscle contraction.Curr Eye Res2005https://conductscience.org/library/papers/16109646PubMed
24066210Effect of intraocular pressure on uveoscleral outflow following cyclodialysis in the monkey eye.Invest Ophthalmol Vis Sci1985https://conductscience.org/library/papers/4066210PubMed
316936121The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.Invest Ophthalmol Vis Sci2006https://conductscience.org/library/papers/16936121PubMed
42086407[Electron microscopy and immunohistochemical studies of the intraocular pressure lowering effect of prostaglandin F2 alpha].Fortschr Ophthalmol1990https://conductscience.org/library/papers/2086407PubMed
517473728Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.J Glaucoma2007https://conductscience.org/library/papers/17473728PubMed
614733708Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.J Ocul Pharmacol Ther2003https://conductscience.org/library/papers/14733708PubMed
712454040Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells.Invest Ophthalmol Vis Sci2002https://conductscience.org/library/papers/12454040PubMed
810509658Flow after prostaglandin E1 is mediated by receptor-coupled adenylyl cyclase in human anterior segments.Invest Ophthalmol Vis Sci1999https://conductscience.org/library/papers/10509658PubMed
914583136Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation.J Ocul Pharmacol Ther2003https://conductscience.org/library/papers/14583136PubMed
1017444800A modified in vitro method for aqueous humor outflow studies in enucleated porcine eyes.J Ocul Pharmacol Ther2007https://conductscience.org/library/papers/17444800PubMed
1111797317Enhancement of scleral macromolecular permeability with prostaglandins.Trans Am Ophthalmol Soc2001https://conductscience.org/library/papers/11797317PubMed
123190548Ultrastructural evidence for lymphatic capillaries in the primate choroid.Arch Ophthalmol1988https://conductscience.org/library/papers/3190548PubMed
1316505029Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.Invest Ophthalmol Vis Sci2006https://conductscience.org/library/papers/16505029PubMed
1412623831Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.Ophthalmology2003https://conductscience.org/library/papers/12623831PubMed
1510369592Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway.Arch Ophthalmol1999https://conductscience.org/library/papers/10369592PubMed
1615557445Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.Invest Ophthalmol Vis Sci2004https://conductscience.org/library/papers/15557445PubMed
176581147Prostaglandin production by human trabecular cells: in vitro inhibition by dexamethasone.Invest Ophthalmol Vis Sci1983https://conductscience.org/library/papers/6581147PubMed
1811726622Mechanisms of action of unoprostone on trabecular meshwork contractility.Invest Ophthalmol Vis Sci2001https://conductscience.org/library/papers/11726622PubMed
1915650608Effects of travoprost on aqueous humor dynamics in monkeys.J Glaucoma2005https://conductscience.org/library/papers/15650608PubMed
209154279Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function.Surv Ophthalmol1997https://conductscience.org/library/papers/9154279PubMed

See all 89 referencesDownload CSV of references

Cited by136

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 236 citations.

PMIDTitleJournalYearIn PapersSource
42653864Latanoprost Acid-Brimonidine, a New Amide Prodrug for Glaucoma Management Based on the Concept of Sustained Release.Molecules2026https://conductscience.org/library/papers/42653864PubMed
42631779Global landscape and thematic evolution of glaucoma pharmacotherapy research (1996-2025): A bibliometric and science mapping analysis.Int Ophthalmol2026https://conductscience.org/library/papers/42631779PubMed
42396508Transcriptomic Atlas of Human Trabecular Meshwork Uncovers the Cellular Landscape and Provides Insights into Glaucoma Pathophysiology.Res Sq2026https://conductscience.org/library/papers/42396508PubMed
42232614
A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension.
Clin Ophthalmol2026https://conductscience.org/library/papers/42232614PubMed
42154749Evolution of intraocular pressure after cataract surgery in nonglaucomatous patients: A post-hoc analysis of PERCEPOLIS clinical trial data.PLoS One2026https://conductscience.org/library/papers/42154749PubMed
41734022Lipidomic analysis reveals drug-induced lipoxin synthesis in glaucoma treatment.JCI Insight2026https://conductscience.org/library/papers/41734022PubMed
41240260Evaluation of corneal epithelial thickness by anterior segment optical coherence tomography in glaucoma patients receiving topical prostaglandin and dry eye treatment.Int Ophthalmol2025https://conductscience.org/library/papers/41240260PubMed
41047758Effects of Omidenepag Isopropyl Versus Latanoprost Eye Drops on Intraocular Pressure, Pupil Diameter, and Anterior Chamber Parameters in Normal Feline Eyes: A Pilot Study.Vet Ophthalmol2026https://conductscience.org/library/papers/41047758PubMed
40861241Efficacy and safety of prostaglandin drugs for elevated intraocular pressure: a Bayesian network meta-analysis.Front Med (Lausanne)2025https://conductscience.org/library/papers/40861241PubMed
40570009Increased sensitivity of primary aniridia limbal stromal cells to travoprost, leading to elevated migration and MMP-9 protein levels, in vitro.PLoS One2025https://conductscience.org/library/papers/40570009PubMed
40224211Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review.Front Ophthalmol (Lausanne)2025https://conductscience.org/library/papers/40224211PubMed
40149925Effects of Brimonidine, Latanoprost, and Omidenepag on Tunicamycin-Induced Endoplasmic Reticulum Stress and Fibrosis in Human Trabecular Meshwork Cells.Biomolecules2025https://conductscience.org/library/papers/40149925PubMed
39951397Adult male-specific inverse association between dry eye disease and intraocular pressure: KNHANES 2010-2012.PLoS One2025https://conductscience.org/library/papers/39951397PubMed
39902753Development of a conjunctival contact-type drug delivery device for latanoprost using hyaluronic acid.Drug Deliv2025https://conductscience.org/library/papers/39902753PubMed
39867351Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study.Clin Ophthalmol2025https://conductscience.org/library/papers/39867351PubMed
39769228Association of Matrix Metalloproteinases Polymorphisms with Glaucoma Risk, Glaucoma Phenotype, and Response to Treatment with Selective Laser Trabeculoplasty or Latanoprost.Int J Mol Sci2024https://conductscience.org/library/papers/39769228PubMed
39458903Roles of Prostaglandins and Hydrogen Sulfide in an Outflow Model of the Porcine Ocular Anterior Segment Ex Vivo.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39458903PubMed
39328825Subconjunctival Administration of an Adeno-Associated Virus Expressing Stanniocalcin-1 Provides Sustained Intraocular Pressure Reduction in Mice.Ophthalmol Sci2025https://conductscience.org/library/papers/39328825PubMed
39051019Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial.Clin Ophthalmol2024https://conductscience.org/library/papers/39051019PubMed
38642251Development of Cell Culture Platforms for Study of Trabecular Meshwork Cells and Glaucoma Development.Tissue Eng Regen Med2024https://conductscience.org/library/papers/38642251PubMed

See all 136 cited byDownload CSV of cited by

Genes34

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AQP1358PubTator's text mininghttps://conductscience.org/library/genes/358NCBI Gene
CCN13491PubTator's text mininghttps://conductscience.org/library/genes/3491NCBI Gene
CCN21490PubTator's text mininghttps://conductscience.org/library/genes/1490NCBI Gene
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906NCBI Gene
EDNRA1909PubTator's text mininghttps://conductscience.org/library/genes/1909NCBI Gene
EPB422038PubTator's text mininghttps://conductscience.org/library/genes/2038NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESRRB2103PubTator's text mininghttps://conductscience.org/library/genes/2103NCBI Gene
FGL210875PubTator's text mininghttps://conductscience.org/library/genes/10875NCBI Gene
IFI4410561PubTator's text mininghttps://conductscience.org/library/genes/10561NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
MAPK35595PubTator's text mininghttps://conductscience.org/library/genes/5595NCBI Gene
MMP14312PubTator's text mininghttps://conductscience.org/library/genes/4312NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
MMP23B8510PubTator's text mininghttps://conductscience.org/library/genes/8510NCBI Gene
MMP34314PubTator's text mininghttps://conductscience.org/library/genes/4314NCBI Gene
MT-CO24513PubTator's text mininghttps://conductscience.org/library/genes/4513NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene
PLA2G1B5319PubTator's text mininghttps://conductscience.org/library/genes/5319NCBI Gene
PTGDR5729PubTator's text mininghttps://conductscience.org/library/genes/5729NCBI Gene

See all 34 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19038618

GET https://conductscience.org/api/papers/v1/19038618/references?page=2